Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

POPCICLE: Effect of Low Dose Continuous Treatment With Ciclesonide Over One Year on the Time to First Exacerbation in Children With Mild Asthma Versus Intermittent Treatment for Exacerbations.

Trial Profile

POPCICLE: Effect of Low Dose Continuous Treatment With Ciclesonide Over One Year on the Time to First Exacerbation in Children With Mild Asthma Versus Intermittent Treatment for Exacerbations.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Apr 2017

At a glance

  • Drugs Ciclesonide (Primary) ; Corticosteroids
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms POPCICLE
  • Sponsors ALTANA Pharma
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 07 Aug 2012 Nycomed Canada added as trial company and lead trial centre as reported by European Clinical Trials Database record.
    • 07 May 2012 Company added to the associations field as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top